Skip to main content

Abstract

Mood disorder in over 2,200 pregnancies of over 1,100 women was examined to determine the risk for an episode. Among these women, 22.7% of those with bipolar disorder experienced an episode during pregnancy and 51.5% during the postpartum period. In comparison, 4.6% of those with unipolar disorder experienced an episode during pregnancy and 29.8% during the postpartum period. First lifetime episodes of mood disorder during the perinatal period occurred for 7.6% of women. Women who already had a mood disorder before their first pregnancy had the highest risk. These high risks are consistent with recommendations for close monitoring and continued treatment during and after pregnancy.

Abstract

Objective:

The risks of major affective episodes during pregnancy and during the postpartum period have rarely been compared in large samples across diagnoses. The authors hypothesized that perinatal episodes would mainly be depressive, would occur more in the postpartum than the prenatal period, and would be more prevalent with bipolar than unipolar depressive disorders.

Method:

The authors pooled clinical information on 2,252 pregnancies of 1,162 women with clinically treated DSM-IV bipolar I disorder (479 pregnancies/283 women), bipolar II disorder (641/338), or recurrent major depressive disorder (1,132/541) to compare rates of affective episode types by diagnosis during pregnancy and the postpartum period and to identify risk factors.

Results:

Among women with bipolar disorder, 23% had illness episodes during pregnancy and 52% during the postpartum period. Among women with unipolar depression, 4.6% had illness episodes during pregnancy and 30% during the postpartum period. Based on exposure-adjusted risk per pregnancy, episodes were 3.5 times more prevalent during the postpartum period than during pregnancy, and the risk was consistently higher with bipolar disorder. Depression was the most frequent morbidity during and following pregnancy. In multivariate modeling, factors associated with affective episodes in pregnancy, in descending order, were younger age at onset, previous postpartum episodes, fewer years of illness, bipolar disorder, fewer children, and not being married. Postpartum episodes were associated with younger age at onset, illness during pregnancy, bipolar disorder, fewer children, and more education. Moreover, pregnancy was less likely and perinatal episodes more likely if diagnosis preceded a first pregnancy. First lifetime episodes occurred in the perinatal period in 7.6% of cases.

Conclusions:

Among women with major affective disorders, illness risk was much greater during the postpartum period than during pregnancy. Illness mainly involved depression and was strongly associated with younger age at illness onset, bipolar disorder, and high lifetime occurrence rates. The relative risk during pregnancy compared with nonpregnant periods remains uncertain.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1179 - 1185
PubMed: 21799064

History

Received: 26 January 2011
Revision received: 4 March 2011
Accepted: 18 April 2011
Published online: 1 November 2011
Published in print: November 2011

Authors

Details

Adele C. Viguera, M.D., M.P.H.
From the Department of Psychiatry, Harvard Medical School, Boston; the International Consortium for Bipolar Disorder Research, McLean Hospital, Boston; the Neurological Institute, Department of Psychiatry, Cleveland Clinic, Cleveland; the Perinatal Unit, Massachusetts General Hospital, Boston; the Lucio Bini Mood Disorders Center, Cagliari, Sardinia, Italy; and the Lucio Bini Mood Disorders Center, Rome.
Leonardo Tondo, M.D., M.Sc.
From the Department of Psychiatry, Harvard Medical School, Boston; the International Consortium for Bipolar Disorder Research, McLean Hospital, Boston; the Neurological Institute, Department of Psychiatry, Cleveland Clinic, Cleveland; the Perinatal Unit, Massachusetts General Hospital, Boston; the Lucio Bini Mood Disorders Center, Cagliari, Sardinia, Italy; and the Lucio Bini Mood Disorders Center, Rome.
Alexia E. Koukopoulos, M.D.
From the Department of Psychiatry, Harvard Medical School, Boston; the International Consortium for Bipolar Disorder Research, McLean Hospital, Boston; the Neurological Institute, Department of Psychiatry, Cleveland Clinic, Cleveland; the Perinatal Unit, Massachusetts General Hospital, Boston; the Lucio Bini Mood Disorders Center, Cagliari, Sardinia, Italy; and the Lucio Bini Mood Disorders Center, Rome.
Daniela Reginaldi, M.D.
From the Department of Psychiatry, Harvard Medical School, Boston; the International Consortium for Bipolar Disorder Research, McLean Hospital, Boston; the Neurological Institute, Department of Psychiatry, Cleveland Clinic, Cleveland; the Perinatal Unit, Massachusetts General Hospital, Boston; the Lucio Bini Mood Disorders Center, Cagliari, Sardinia, Italy; and the Lucio Bini Mood Disorders Center, Rome.
Beatrice Lepri, Psy.D.
From the Department of Psychiatry, Harvard Medical School, Boston; the International Consortium for Bipolar Disorder Research, McLean Hospital, Boston; the Neurological Institute, Department of Psychiatry, Cleveland Clinic, Cleveland; the Perinatal Unit, Massachusetts General Hospital, Boston; the Lucio Bini Mood Disorders Center, Cagliari, Sardinia, Italy; and the Lucio Bini Mood Disorders Center, Rome.
Ross J. Baldessarini, M.D.
From the Department of Psychiatry, Harvard Medical School, Boston; the International Consortium for Bipolar Disorder Research, McLean Hospital, Boston; the Neurological Institute, Department of Psychiatry, Cleveland Clinic, Cleveland; the Perinatal Unit, Massachusetts General Hospital, Boston; the Lucio Bini Mood Disorders Center, Cagliari, Sardinia, Italy; and the Lucio Bini Mood Disorders Center, Rome.

Notes

Address correspondence to Dr. Baldessarini ([email protected] (e-mail).

Funding Information

Dr. Viguera has received research support from NIMH, the Epilepsy Foundation, AstraZeneca, Bristol-Myers Squibb, Ortho-McNeil-Janssen Pharmaceuticals, Pfizer, and Sunovion and has served on the advisory board of Medco Health. The other authors report no financial relationships with commercial interests.Supported in part by NIH grants MH-011609 and MH-071762 (to Dr. Viguera), the Lucio Bini Private Donors Mood Disorders Research Fund (to Dr. Tondo), a grant from the Bruce J. Anderson Foundation (to Dr. Baldessarini), and the McLean Private Donors Mood Disorders Research Fund (to Dr. Baldessarini).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share